Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts

Cancer Research

Volumn 70, Issue 11, 2010, Pages 4580-4589

  Huang, Chih Fen ^a,c   Lira, Cristina ^a   Chu, Khoi ^a   Bilen, Mehmet Asim ^a   Lee, Yu Chen ^a   Ye, Xiangcang ^a   Kim, Soo Mi ^a   Ortiz, Angelica ^a   Wu, Fe Lin Lin ^c   Logothetis, Christopher J ^a   Yu Lee, Li Yuan ^b   Lin, Sue Hwa ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN 11; CELL ADHESION MOLECULE; DOCETAXEL; MATRILYSIN; MATRIX METALLOPROTEINASE 15; UNCLASSIFIED DRUG;

ARTICLE; BONE METASTASIS; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; OSTEOBLAST; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION;

CADHERINS; CELL COMMUNICATION; CELL GROWTH PROCESSES; CELL MOVEMENT; COCULTURE TECHNIQUES; CYTOPLASM; DOWN-REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; NEOPLASM INVASIVENESS; OSTEOBLASTS; PROSTATIC NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; TRANSFECTION;

EID: 77953153372     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-3016     Document Type: Article

References (37)

1. Takeichi M. Morphogenetic roles of classic cadherins. Curr Opin Cell Biol 1995;7:619-627
2. Gumbiner BM. Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol 2005;6:622-634
3. Wheelock MJ, Shintani Y, Maeda M, Fukumoto Y, Johnson KR. Cadherin switching. J Cell Sci 2008;121:727-735
4. Tomita K, van Bokhoven A, van Leenders GJ, et al. Cadherin switching in human prostate cancer progression. Cancer Res 2000;60:3650-3654 (Pubitemid 30482189)
5. Schmidmaier R, Baumann P. ANTI-ADHESION evolves to a promising therapeutic concept in oncology. Curr Med Chem 2008;15:978-990
6. Tu S-M, Lin S-H. Clinical aspects of bone metastases in prostate cancer. In: Keller ET, Chung LW, editors. The Biology of Bone Metastases. Boston, MA: Kluwer Academic Publishers; 2004, p. 23-46.
7. Ye XC, Choueiri M, Tu SM, Lin SH. Biology and clinical management of prostate cancer bone metastasis. Front Biosci 2007;12:3273-3286
8. Chu K, Cheng C-J, Ye X, et al. Cadherin-11 promotes the metastasis of prostate cancer cells to bone. Mol Cancer Res 2008;6:1259-1267
9. Kawaguchi J, Azuma Y, Hoshi K, et al. Targeted disruption of cadherin-11 leads to a reduction in bone density in calvaria and long bone metaphyses. J Bone Miner Res 2001;16:1265-1271
10. Tamura D, Hiraga T, Myoui A, Yoshikawa H, Yoneda T. Cadherin-11-mediated interactions with bone marrow stromal/osteoblastic cells support selective colonization of breast cancer cells in bone. Int J Oncol 2008;33:17-24.
11. Okazaki M, Takeshita S, Kawai S, et al. Molecular cloning and characterization of OB-cadherin, a new member of cadherin family expressed in osteoblasts. J Biol Chem 1994;269:12092-12098
12. Frixen UH, Behrens J, Sachs M, et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991;113:173-185 (Pubitemid 21909684)
13. Mariotti A, Perotti A, Sessa C, Rüegg C. N-cadherin as a therapeutic target in cancer. Expert Opin Investig Drugs 2007;16:451-465
14. Lira CB, Chu K, Lee YC, Hu MC, Lin S-H. Expression of the extracellular domain of OB-cadherin as an Fc fusion protein using bicistronic retroviral expression vector. Protein Expr Purif 2008;61:220-226
15. Wu TT, Sikes RA, Cui Q, et al. Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines. Int J Cancer 1998;77:887-894
16. Thalmann GN, Sikes RA, Wu TT, et al. LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis. Prostate 2000;44:91-103.
17. Lee Y-C, Cheng C-J, Huang M, et al. Androgen depletion upregulates cadherin-11 expression in prostate cancer. J Pathol 2010;221:68-76.
18. Partridge NC, Alcorn D, Michelangeli VP, Ryan G, Martin TJ. Morphological and biochemical characterization of four clonal osteogenic sarcoma cell lines of rat origin. Cancer Res 1983;43:4308-4314 (Pubitemid 13044057)
19. Majeska RJ, Nair BC, Rodan GA. Glucocorticoid regulation of alkaline phosphatase in the osteoblastic osteosarcoma cell line ROS 17/2.8. Endocrinology 1985;116:170-179
20. Sudo H, Kodama HA, Amagai Y, Yamamoto S, Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 1983;96:191-198
21. Rodan SB, Imai Y, Thiede MA, et al. Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties. Cancer Res 1987;47:4961-4966 (Pubitemid 17143047)
22. Katagiri T, Yamaguchi A, Komaki M, et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 1994;127:1755-1766
23. Shaner NC, Steinbach PA, Tsien RY. A guide to choosing fluorescent proteins. Nat Methods 2005;2:905-909
24. Finnemann S, Mitrik I, Hess M, Otto G, Wedlich D. Uncoupling of XB/U-cadherin-catenin complex formation from its function in cell-cell adhesion. J Biol Chem 1997;272:11856-11862
25. Yap AS, Niessen CM, Gumbiner BM. The juxtamembrane region of the cadherin cytoplasmic tail supports lateral clustering, adhesive strengthening, and interaction with p120ctn. J Cell Biol 1998;141:779-789
26. Nagafuchi A, Takeichi M. Cell binding function of E-cadherin is regulated by the cytoplasmic domain. EMBO J 1988;7:3679-3684
27. Nagafuchi A, Takeichi M. Transmembrane control of cadherin-mediated cell adhesion: a 94 kDa protein functionally associated with a specific region of the cytoplasmic domain of E-cadherin. Cell Regul 1989;1:37-44.
28. Lee DM, Kiener HP, Agarwal SK, et al. Cadherin-11 in synovial lining formation and pathology in arthritis. Science 2007;315:1006-1010
29. Pishvaian MJ, Feltes CM, Thompson P, Bussemakers MJ, Schalken JA, Byers SW. Cadherin-11 is expressed in invasive breast cancer cell lines. Cancer Res 1999;59:947-952 (Pubitemid 29086753)
30. Shibata T, Ochiai A, Gotoh M, Machinami R, Hirohashi S. Simultaneous expression of cadherin-11 in signet-ring cell carcinoma and stromal cells of diffuse-type gastric cancer. Cancer Lett 1996;99:147-153
31. Monahan TS, Andersen ND, Panossian H, et al. A novel function for cadherin 11/osteoblast-cadherin in vascular smooth muscle cells: modulation of cell migration and proliferation. J Vasc Surg 2007;45:581-589
32. Boscher C, Mège RM. Cadherin-11 interacts with the FGF receptor and induces neurite outgrowth through associated downstream signalling. Cell Signal 2008;20:1061-1072
33. Kiener HP, Stipp CS, Allen PG, Higgins JM, Brenner MB. The cadherin-11 cytoplasmic juxtamembrane domain promotes α-catenin turnover at adherens junctions and intercellular motility. Mol Biol Cell 2006;17:2366-2376
34. Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 1999;147:631-644
35. Vleminckx K, Vakaet L, Jr., Mareel M, Fiers W, Van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991;66:107-119 (Pubitemid 121001351)
36. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998;392:190-193
37. Lin S-H, Cheng CJ, Lee Y-C, et al. A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation. Oncogene 2008;27:5195-5203